[go: up one dir, main page]

AU5196099A - Enhancer of cell differentiation induction factor - Google Patents

Enhancer of cell differentiation induction factor

Info

Publication number
AU5196099A
AU5196099A AU51960/99A AU5196099A AU5196099A AU 5196099 A AU5196099 A AU 5196099A AU 51960/99 A AU51960/99 A AU 51960/99A AU 5196099 A AU5196099 A AU 5196099A AU 5196099 A AU5196099 A AU 5196099A
Authority
AU
Australia
Prior art keywords
enhancer
cell differentiation
differentiation induction
induction factor
factor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51960/99A
Inventor
Yukio Fujisawa
Masatoshi Hazama
Haruhiko Makino
Takashi Sohda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of AU5196099A publication Critical patent/AU5196099A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/67Phosphorus compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU51960/99A 1998-08-12 1999-08-11 Enhancer of cell differentiation induction factor Abandoned AU5196099A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP22830098 1998-08-12
JP10/228300 1998-08-12
PCT/JP1999/004338 WO2000009100A2 (en) 1998-08-12 1999-08-11 Benzothiepine compounds as enhancer of cell differentiation induction factor

Publications (1)

Publication Number Publication Date
AU5196099A true AU5196099A (en) 2000-03-06

Family

ID=16874304

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51960/99A Abandoned AU5196099A (en) 1998-08-12 1999-08-11 Enhancer of cell differentiation induction factor

Country Status (5)

Country Link
EP (1) EP1105140A2 (en)
AR (1) AR020158A1 (en)
AU (1) AU5196099A (en)
CA (1) CA2340165A1 (en)
WO (1) WO2000009100A2 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0460488B1 (en) * 1990-05-30 2001-07-11 Takeda Chemical Industries, Ltd. Sulfur-containing heterocyclic compounds
TW403757B (en) * 1994-12-28 2000-09-01 Takeda Chemical Industries Ltd Optically active benzothiepin derivative, its preparation and use
WO1996025929A1 (en) * 1995-02-21 1996-08-29 Takeda Chemical Industries, Ltd. Use of helioxanthin as an enhancer of cell differentiation inducing factors
CA2221784A1 (en) * 1995-06-05 1996-12-12 Takeda Chemical Industries, Ltd. Osteogenetic promoting pharmaceutical composition
ATE226078T1 (en) * 1996-08-26 2002-11-15 Takeda Chemical Industries Ltd PHARMACEUTICAL COMPOSITION CONTAINING AN OSTEOGENESIS PROMOTING AGENT AND A POLYETHYLENE GLYCOL
DE69721794T2 (en) * 1996-09-06 2004-03-18 Takeda Chemical Industries, Ltd. CONDENSED 4,5,6,7-TETRAHYDROBENZO C] THIOPHENE AS ACCELERATING THE EFFECT OF THE CELL DIFFERENTIATION INDUCTION FACTOR

Also Published As

Publication number Publication date
WO2000009100A2 (en) 2000-02-24
AR020158A1 (en) 2002-04-10
CA2340165A1 (en) 2000-02-24
WO2000009100A3 (en) 2000-08-24
EP1105140A2 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
AU2517397A (en) Document of value
AU8150694A (en) Extended radio cell
AU3444897A (en) Planar transformer
AU7074598A (en) Aluminium production cell and cathode
AU8031298A (en) Aluminium production cell design
AUPP502598A0 (en) Trimaran construction
AU4296397A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU3769097A (en) Substituted bisindolylmaleimides for the inhibition of cell proliferation
AU5235299A (en) Spectral topography of mammalian matter
AU1311297A (en) Quinolin-2-(1H)-ones
AU1394000A (en) Multi-compartment mill
AU5391899A (en) Camping range
AU2682895A (en) EG Cells of Ungulates
AU4926099A (en) Planar transformer
AU5504999A (en) Production of proteins
AU5849300A (en) Proliferation differentiation factor
AU1690199A (en) Novel imidazole derivatives
AU4677496A (en) Use of helioxanthin as an enhancer of cell differentiation inducing factors
AU8072498A (en) Heregulin-like factor
AU5196099A (en) Enhancer of cell differentiation induction factor
AU6160598A (en) Differentiation enhancing factors and uses therefor
AU3363997A (en) Means of transport with increased range
AU1000097A (en) Direct access paging for wireless sets
AU4186999A (en) Crowne zoysiagrass plant
AU4153699A (en) Reactive power compensation

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase